Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2026)

Takeda Pharmaceutical's Change in Inventory history runs 9 years deep, the most recent figure standing at $119.2 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 464.42% year-over-year to $119.2 million in Q1 2026; TTM through Mar 2026 was -$414.3 million, a 77.38% decrease from a year earlier, with the FY2026 full-year figure at -$407.2 million, down 77.35% from the prior year.
• Change in Inventory rose to $119.2 million in Q1 2026 per TAK's latest filing, from -$246.7 million in the prior quarter.
• Across five years, Change in Inventory topped out at $139.7 million in Q4 2024 and bottomed at -$342.0 million in Q4 2023.
• The 5-year median for Change in Inventory is -$90.3 million (2025), against an average of -$123.7 million.
• Across the five-year window, Change in Inventory slumped 608.63% in 2023 and surged 464.42% in 2026, its largest moves.
• Year by year, Change in Inventory stood at -$130.7 million in 2022, then plunged by 161.71% to -$342.0 million in 2023, then jumped by 140.85% to $139.7 million in 2024, then sank by 276.58% to -$246.7 million in 2025, then jumped by 148.34% to $119.2 million in 2026.
• Per Business Quant, the three latest TAK Change in Inventory figures stand at $119.2 million (Q1 2026), -$246.7 million (Q4 2025), and -$196.6 million (Q3 2025).